Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Chuck Royce Unloads Some Shares of This Restaurant Franchiser

Royce & Associates, Cosi: Chuck Royce‘s Royce & Associates recently lowered their position in Cosi Inc (NASDAQ:COSI), now holding 7.12% of the company. In an amended 13D SEC filing, Royce reported ownership of some 1.29 million shares, versus around 1.58 million shares posted in its latest 13F filing. At the current stock price of Cosi’s stock, the total value of the shares amounts to around $2.8 million.

Chuck Royce

Cosi had a net loss of over 2.13 million in the second quarter of the year, which represents $0.12 per share, versus an income of $77,000 posted for the same period of 2012. The revenues of the company declined by some $2.9 million and totaled around $23.4 million. Also, in August the company received a notice from the Listing Qualifications Department of the Nasdaq Stock Market, which stated that due to the insufficiency of stockholder equity, which is below $10 million, the company had to file a plan to get back to compliance levels, the company said in a statement.

Alexander Mitchell‘s Scopus Asset Management disclosed around 256,300 shares of Cosi in its latest 13F.

Disclosure: none

Recommended Reading:

Brian Bares Buys RealD, XPO; Sells Interactive Intelligence

Ariel Investments Owns Over 10% of Astro-Med and Rosetta Stone

Daniel Lewis’s Orange Capital Sends Letter to PHH Corp Encouraging Spinoffs

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!